Diabetic macular edema can result in low vision or vision loss. Early treatment can help preserve vision longer. Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and ... waiting' until symptoms worsen may not ...

Diabetic macular edema occurs when fluid leaks from blood vessels in the retina, causing swelling in the macula that can lead to vision loss in people with diabetes. Let's explore the latest ...

Regular monitoring helps detect early signs of macular edema ... infection symptoms. Proper hygiene, regular hand washing, and avoiding eye rubbing reduce infection risks. While diabetes creates ...

(RTTNews) - EyePoint Pharmaceuticals, Inc. (EYPT), Wednesday announced positive six-month results from the ongoing Phase 2 VERONA clinical trial, evaluating Duravyu for the treatment of diabetic ...

Diabetic macular edema (DME) is a consequence of diabetic ... The exam is painless and can reveal early changes in the eyes ...

This is a higher dose, longer-acting form of the drug, and it’s used to treat wet AMD, diabetic retinopathy, and diabetic macular edema in adults ... But if you have any symptoms that are ...

Faricimab should be readministered with caution in patients who develop mild intraocular inflammation with a previous dose of ...

today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). “OCU200 has the potential to change the treatment landscape for DME ...

Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...